Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Journal of molecular medicine (Berlin, Germany), 95(3), 323333
This positions FOXO4-DRI within advanced molecular longevity research rather than endocrine or metabolic peptide categories
A vendor cannot borrow the strongest evidence for one ingredient and automatically apply it to the entire product unless the formulation and testing support that claim
Critical limitations identified in the systematic review include predominant use of small rodent models (primarily rats), short follow-up periods relative to human healing timelines, variable dosing regimens complicating dose-response assessment, and lack of standardized outcome measures across studies
They offer several advantages over traditional injectables or powders
US$ 21.63
US$ 21.96
US$ 29.31
US$ 27.83
US$ 27.81
US$ 27.21
US$ 28.35
US$ 22.89
US$ 20.90
